223 related articles for article (PubMed ID: 34113406)
1. Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy.
Deng Z; Chen L; Tan J; Wang S; Liu D; Wang J; Jiang C; Yang J; Xu B
Dis Markers; 2021; 2021():9964232. PubMed ID: 34113406
[TBL] [Abstract][Full Text] [Related]
2. Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease.
Starks VS; Reinshagen KL; Lee NG; Freitag SK
Orbit; 2020 Apr; 39(2):77-83. PubMed ID: 31057005
[No Abstract] [Full Text] [Related]
3. Visual function changes of dysthyroid optic neuropathy and ROC curve analysis for early diagnostic indicators.
Wang S; Wang J; Chen L; Tan J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1197-1202. PubMed ID: 37875359
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
[TBL] [Abstract][Full Text] [Related]
5. Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
Stoyanova NS; Konareva-Kostianeva MI; Mitkova-Hristova VT
Folia Med (Plovdiv); 2020 Jun; 62(2):418-423. PubMed ID: 32666771
[TBL] [Abstract][Full Text] [Related]
6. Comparison of surgical effect in active and inactive Dysthyroid Optic Neuropathy after Endoscopic Transnasal Medial Orbital Decompression.
Lv X; Gao Y; Ma Y; Li C; Ren Y; Zhang Z; Bao Y; Su S; Lu R
Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):281-293. PubMed ID: 37530848
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic methods for dysthyroid optic neuropathy: A systematic review and analysis.
Sio SWC; Chan BKT; Aljufairi FMAA; Sebastian JU; Lai KKH; Tham CCY; Pang CP; Chong KKL
Surv Ophthalmol; 2024; 69(3):403-410. PubMed ID: 38007201
[TBL] [Abstract][Full Text] [Related]
8. Extraocular muscle volume index at the orbital apex with optic neuritis: a combined parameter for diagnosis of dysthyroid optic neuropathy.
Song C; Luo Y; Huang W; Duan Y; Deng X; Chen H; Yu G; Huang K; Xu S; Lin X; Wang Y; Shen J
Eur Radiol; 2023 Dec; 33(12):9203-9212. PubMed ID: 37405499
[TBL] [Abstract][Full Text] [Related]
9. Quantitative computed tomographic predictors of compressive optic neuropathy in patients with thyroid orbitopathy: a volumetric analysis.
Weis E; Heran MK; Jhamb A; Chan AK; Chiu JP; Hurley MC; Rootman J
Ophthalmology; 2012 Oct; 119(10):2174-8. PubMed ID: 22709420
[TBL] [Abstract][Full Text] [Related]
10. Clinical and soft-tissue computed tomographic predictors of dysthyroid optic neuropathy: refinement of the constellation of findings at presentation.
Weis E; Heran MK; Jhamb A; Chan AK; Chiu JP; Hurley MC; Rootman J
Arch Ophthalmol; 2011 Oct; 129(10):1332-6. PubMed ID: 21987676
[TBL] [Abstract][Full Text] [Related]
11. Dysthyroid optic neuropathy: evaluation and management.
Dolman PJ
J Endocrinol Invest; 2021 Mar; 44(3):421-429. PubMed ID: 32729049
[TBL] [Abstract][Full Text] [Related]
12. Peripapillary and Macular Vessel Density in Dysthyroid Optic Neuropathy: An Optical Coherence Tomography Angiography Study.
Zhang T; Xiao W; Ye H; Chen R; Mao Y; Yang H
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1863-1869. PubMed ID: 31042792
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors of development of dysthyroid optic neuropathy among individuals with thyroid-eye disease.
Kemchoknatee P; Thongsawangchai N; Srisombut T; Tangon D; Chantra S
Eur J Ophthalmol; 2024 May; 34(3):834-842. PubMed ID: 37661652
[TBL] [Abstract][Full Text] [Related]
14. Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye disease.
Berger M; Matlach J; Pitz S; Berres M; Axmacher F; Kahaly GJ; Brockmann MA; Müller-Eschner M
Sci Rep; 2022 Apr; 12(1):6259. PubMed ID: 35428798
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional soft tissue reconstruction and volume measurement used for the diagnosis of dysthyroid optic neuropathy.
Ma L; Wang M; Zhang Z; Jiang X; Hou Z; Li D
Graefes Arch Clin Exp Ophthalmol; 2024 Jun; 262(6):1919-1924. PubMed ID: 38294512
[TBL] [Abstract][Full Text] [Related]
16. Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures.
Gonçalves AC; Silva LN; Gebrim EM; Matayoshi S; Monteiro ML
Clinics (Sao Paulo); 2012 Aug; 67(8):891-6. PubMed ID: 22948455
[TBL] [Abstract][Full Text] [Related]
17. Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.
Ponto KA; Diana T; Binder H; Matheis N; Pitz S; Pfeiffer N; Kahaly GJ
J Endocrinol Invest; 2015 Jul; 38(7):769-77. PubMed ID: 25736545
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy].
Wang Y; Li YY; Yang N; Ma R; Xiao LH
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):416-423. PubMed ID: 28606262
[TBL] [Abstract][Full Text] [Related]
19. Real-World Experience With Teprotumumab in Patients With Dysthyroid Optic Neuropathy.
Tamhankar MA; Pradeep T; Chen Y; Briceño CA
J Neuroophthalmol; 2024 Mar; 44(1):74-79. PubMed ID: 37751310
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients.
Vermot-Desroches V; Thia-Soui-Tchong K; Raymond P; Filip A; Orgiazzi J; Jouanneau E; Froment Tilikete C; Borson-Chazot F; Manet R; Abeillon Du Payrat J
Ann Endocrinol (Paris); 2023 Aug; 84(4):430-439. PubMed ID: 37086950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
